Pharmacology

Action Mechanism of Action Reference
AGONIST Parathyroid hormone receptor agonist FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hypoparathyroidism 4 D007011 ClinicalTrials
Osteoporosis 3 D010024 ClinicalTrials
Osteoporosis, Postmenopausal 1 D015663 ClinicalTrials
Psoriasis 1 D011565 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
13.63
Nervous system disorders
12.56
Musculoskeletal and connective tissue disorders
11.14
Investigations
9.19
Injury, poisoning and procedural complications
8.55
Skin and subcutaneous tissue disorders
6.6
Gastrointestinal disorders
5.96
Metabolism and nutrition disorders
4.78
Vascular disorders
3.78
Psychiatric disorders
3.66
Respiratory, thoracic and mediastinal disorders
3.24
Cardiac disorders
3.18
Product issues
2.75
Renal and urinary disorders
2.35

Cross References

Resources Reference
CAS NUMBER 9002-64-6
ChEMBL CHEMBL2108078
FDA SRS N19A0T0E5J